Playback speed
×
Share post
Share post at current time
0:00
/
0:00
19
10

Common Mucosal System and Immunobiotics: Courageous Discourse with Dr. Robert Clancy

Next Frontier for Protection Against Respiratory Disease in the Era of Pandemics
19
10

By Peter A. McCullough, MD, MPH

Many lay persons don’t know that our gastro-intestinal system is a major player in providing immunity to our lungs. By swallowing secretions (1-2 cups) normally per day and ~10 times that quantity during acute infections, we ingest a large number of viruses and bacteria from our nose, mouth, throat, and lungs. Dr. Robert Clancy is the world’s expert on this topic and deserves great credit over his storied career in breakthrough understanding of how the respiratory, immune, and gastrointestinal systems are all connected.

Please listen to the entire interview to get the key concepts of what Clancy has termed the “Common Mucosal System” and the innovation of giving “immunobiotics” or sterilized killed non-typable Hemophilus species (abbreviated NTH in the interview) in a tablet to patients in order to stimulate the immune system and protect the lungs from recurrent infections and pneumonia. His work cut serious infections in those with emphysema in half. Can you imagine how powerful this nonspecific oral, over-the-counter approach would be for the next pandemic?

Now fully published July 19, 2023:

Clancy RL The Common Mucosal System Fifty Years on: From Cell Traffic in the Rabbit to Immune Resilience to SARS-CoV-2 Infection by Shifting Risk within Normal and Disease Populations

Dr. Clancy says that good things for the field of medicine and humanity come out after pandemics. It appears he is on the vanguard of a safe and effective breakthrough that could bring us through next time without dependence from big pharma or vaccine developers.

Professor Robert Llewellyn Clancy (AM) Qualifications: MBBS(Hons), BSc(Med), PhD, FRACP, FRCPA

COVID-19: A realistic approach to community management 17 January 2021 Professor Robert Clancy

Clancy, R.L. Immune Resilience to SARS-CoV-2 Infection by Shifting Risk Within Normal and Disease Populations. Preprints.org 2023, 2023070352. https://doi.org/10.20944/preprints202307.0352.v1

Please subscribe as a paying or founder member so we can bring you the truth.

Share

Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Discussion about this video

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Authors
Peter A. McCullough, MD, MPH